BB BIOTECH AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.4 CHF | +31.97% |
|
-.--% | -.--% |
| 27/04 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
| 26/04 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.47B | - | |||||
| 56.61B | - | |||||
| 39.62B | ||||||
| 39.25B | ||||||
| 28.28B | ||||||
| 26.44B |
